Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.42 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.42 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.42 |
| ▸ | TRPV6 | Q9H1D0 | 3/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1672441 | 0.82 | ORAI1 (0.46) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL384013 | 0.80 | ORAI1 (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL28664851 | 0.80 | TRPV6 (0.44) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL56273 | 0.78 | ORAI1 (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL20916961 | 0.78 | LMNA (0.54) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL651370 | 0.78 | ORAI1 (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL27008267 | 0.77 | TRPV6 (0.41) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL1237453 | 0.75 | KMT2A (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL1789520 | 0.74 | PKM (0.42) | ORAI1ORAI2ORAI3TRPV6CA4 | |
| SCHEMBL5951647 | 0.74 | ELANE (0.46) | ORAI1ORAI2ORAI3TRPV6CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119752437-A | Organic electroluminescent material containing double main bodies, preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119775266-A | Organic electroluminescent compound, organic electroluminescent material containing double bodies, and light-emitting device | 吉林奥来德光电材料股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119752437-A | Organic electroluminescent material containing double main bodies, preparation method and application thereof | 吉林奥来德光电材料股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| EP-2408729-B1 | NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | CANON KK (JP) | 2015-12-16 | — | — | EP | disclosed |
| US-8580400-B2 | Bichrysene compound and organic light emitting device having the compound | CANON KABUSHIKI KAISHA (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-2408729-A1 | NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | Canon Kabushiki Kaisha (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20110272683-A1 | NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2011-11-10 | — | — | US | disclosed |
| WO-2010107097-A1 | NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2010-09-23 | — | — | WO | disclosed |
| EP-1539158-A1 | ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | GLAXO GROUP LIMITED (GB) | 2005-06-15 | — | — | EP | disclosed |
| WO-2004006922-A1 | ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA | GLAXO GROUP LIMITED (GB) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110272683-A1 | NOVEL BICHRYSENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | PPOX, CRY1, OXER1 | ORAI1 935/4885ORAI2 235/4885ORAI3 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.